Arunjyoti Bio Ventures Ltd Financials
Company Logo

Arunjyoti Bio Ventures Ltd Financial Statement

Arunjyoti Bio Ventures Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue6.46
Operating Expense5.57
Net Profit-0.41
Net Profit Margin-6.35
Earning Per Share-0.35
EBIDTA0.71
Effective Tax Rate-32.58

Arunjyoti Bio Ventures Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual20.43
Operating Expenses Annual17.66
Operating Profit Annual2.81
Interest Annual2.09
Depreciation2.01
Net Profit Annual-0.35
Tax Annual-0.95

Arunjyoti Bio Ventures Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.03
Cash Flow from Operations6.31
Cash Flow from Investing-23.29
Cash Flow from Financing17.04
Cash Flow at the End0.09

Arunjyoti Bio Ventures Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)13.80
PBIT Margin (%)3.96
PBT Margin (%)2.10
Net PROFIT Margin (%)-1.71
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-0.81
Total Debt / Equity (X)21.57
Asset Turnover Ratio (%)0.47

Arunjyoti Bio Ventures Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual40.50
Total Current Assets Annual11.28
Non Current Assets Annual42.71
Total Shareholders Funds Annual1.77
Total Assets Annual53.99

Arunjyoti Bio Ventures Ltd Earning Calls

EPS (INR)

Expected

0.19

Reported

0.19

Surprise

0.00%

Sep 2010

EPS beaten by 0.00%

Get Your FAQs Right

As of Dec 24, 2024, Arunjyoti Bio Ventures Ltd has a market capitalization of 106.24 Cr. Value Research classifies it as a Micro-Cap company.
No, Arunjyoti Bio Ventures Ltd is not debt-free with a debt-to-equity ratio of 29.10.
In FY 2023 , Arunjyoti Bio Ventures Ltd recorded a total revenue of approximately 20.43 Cr marking a significant milestone in the company's financial performance.
Arunjyoti Bio Ventures Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 1.5% and 1.0% annually, respectively..
Arunjyoti Bio Ventures Ltd's current PE ratio is -303.54.
Arunjyoti Bio Ventures Ltd's ROCE averaged 2.0% from the FY ending March 2022 to 2024, with a median of 1.5%. It peaked at 3.8% in March 2022, reflecting strong capital efficiency over the period..
Arunjyoti Bio Ventures Ltd's latest EBIT is Rs. 0.79 Cr, surpassing the average EBIT of Rs. 0.38 Cr over the 5 years..

Built for those who know the

game inside-out.

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions